Skip to main content

Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL Title Category Date Recent Activity
https://sentinelinitiative.org/news-events/publications-presentations/hydroxyurea-utilization-patterns-among-sickle-cell-disease Hydroxyurea Utilization Patterns Among Sickle Cell Disease Patients in the United States, US FDA Sentinel Database Publications and Presentations
Hydroxyurea Utilization Patterns Among Sickle Cell Disease Patients in the United States, US FDA Sentinel Database
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation COVID-19 Pregnancy Study Implementation Methods, Data, & Tools
COVID-19 Pregnancy Study Implementation
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2016 Duration of Follow Up for New Molecular Entities Approved in 2016 Analyses
Duration of Follow Up for New Molecular Entities Approved in 2016
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2014-and Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015 Analyses
Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2010-2012 Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013 Analyses
Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2008-and Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009 Analyses
Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2005-2006 Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007 Analyses
Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2011 Duration of Follow Up for New Molecular Entities Approved in 2011 Analyses
Duration of Follow Up for New Molecular Entities Approved in 2011
Analyses
https://sentinelinitiative.org/methods-data-tools/methods/extending-machine-learning-methods-development-sentinel-follow-analyses Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3) Methods, Data, & Tools
Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3)
Methods, Data, & Tools
https://sentinelinitiative.org/news-events/publications-presentations/who-gets-treated-influenza-surveillance-study-us-food-and Who Gets Treated for Influenza: A Surveillance Study From the US Food and Drug Administration’s Sentinel System Publications and Presentations
Who Gets Treated for Influenza: A Surveillance Study From the US Food and Drug Administration’s Sentinel System
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2021-13th-annual-sentinel-initiative-public-workshop 2021 13th Annual Sentinel Initiative Public Workshop Sentinel Initiative Events
2021 13th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
https://sentinelinitiative.org/news-events/publications-presentations/validation-diagnosis-codes-identify-hospitalized-covid-19 Validation of Diagnosis Codes to Identify Hospitalized COVID-19 Patients in Health Care Claims Data Publications and Presentations
Validation of Diagnosis Codes to Identify Hospitalized COVID-19 Patients in Health Care Claims Data
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/thromboembolic-stroke-algorithm-defined-1 Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis" Methods, Data, & Tools
Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gastrointestinal-bleeding-algorithm-defined-0 Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis" Methods, Data, & Tools
Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/major-extracranial-bleeding-algorithm-defined-1 Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis" Methods, Data, & Tools
Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intracranial-hemorrhage-algorithm-defined-1 Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis" Methods, Data, & Tools
Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2019 Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/engage-sentinel/quarterly-newsletter Quarterly Newsletter Spotlight
Quarterly Newsletter
Spotlight
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/hydroxyurea-use-among-patients-sickle-cell-disease-scd Hydroxyurea Use Among Patients with Sickle Cell Disease (SCD): A Descriptive Analysis Analyses
Hydroxyurea Use Among Patients with Sickle Cell Disease (SCD): A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-major-extracranial-bleeding-0 Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 or Older: An Inverse Probability of Treatment Weighting (IPTW) Analysis Analyses
Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 or Older: An Inverse Probability of Treatment Weighting (IPTW) Analysis
Analyses
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-public-training-day-inverse-probability 2022 Sentinel Public Training Day: Inverse Probability of Treatment Weighting & Innovation Day  Sentinel Initiative Events
2022 Sentinel Public Training Day: Inverse Probability of Treatment Weighting & Innovation Day 
Sentinel Initiative Events
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-pediatric-demographics-and-enrollment Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/methods-data-tools/methods/approaches-handling-partially-observed-confounder-data-electronic-health Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes Methods, Data, & Tools
Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/bamlanivimab-bamlanivimab-and-etesevimab-and-casirivimab Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis Analyses
Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterizing-pregnant-women-and-without-evidence-heart Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis Analyses
Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-monoclonal-antibodies-mabs-under-emergency-use Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis Analyses
Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/hospitalization-and-anaphylaxis-following-monoclonal Hospitalization and Anaphylaxis Following Monoclonal Antibodies (mAb) Use in Patients with COVID-19: A Descriptive Analysis Analyses
Hospitalization and Anaphylaxis Following Monoclonal Antibodies (mAb) Use in Patients with COVID-19: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-monoclonal-antibodies-mabs-under-emergency-use-0 Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: An Updated Descriptive Analysis Analyses
Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: An Updated Descriptive Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-pediatric-members-sentinel-distributed Characterizing Pediatric Members in the Sentinel Distributed Database Publications and Presentations
Characterizing Pediatric Members in the Sentinel Distributed Database
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2 Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis Analyses
Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis
Analyses
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-14th-annual-sentinel-initiative-public-workshop 2022 14th Annual Sentinel Initiative Public Workshop Sentinel Initiative Events
2022 14th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
https://sentinelinitiative.org/news-events/publications-presentations/scalable-phenotyping-safety-outcomes-using-electronic-health Scalable Phenotyping for Safety Outcomes Using Electronic Health Record Data Publications and Presentations
Scalable Phenotyping for Safety Outcomes Using Electronic Health Record Data
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-zarxio-use-updated-signal Outcome Monitoring Following Zarxio Use: An Updated Signal Identification Analysis Analyses
Outcome Monitoring Following Zarxio Use: An Updated Signal Identification Analysis
Analyses
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-sentinel-public-training-signal-identification-among 2023 Sentinel Public Training: Signal Identification Among Infants Following Maternal Medication Use During Pregnancy & Innovation Day Sentinel Initiative Events
2023 Sentinel Public Training: Signal Identification Among Infants Following Maternal Medication Use During Pregnancy & Innovation Day
Sentinel Initiative Events
https://sentinelinitiative.org/news-events/publications-presentations/r-package-perform-routine-structural-missing-data An R Package to Perform Routine Structural Missing Data Investigations in Real-World Data Publications and Presentations
An R Package to Perform Routine Structural Missing Data Investigations in Real-World Data
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/signal-detection-and-refinement-activities-within-fda-s-0 Signal Detection and Refinement Activities within FDA’s Sentinel System Publications and Presentations
Signal Detection and Refinement Activities within FDA’s Sentinel System
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-cannabis-derived-product-users-trinetx-four Characterization of Cannabis-Derived Product Users in TriNetX: Four Descriptive Analyses Analyses
Characterization of Cannabis-Derived Product Users in TriNetX: Four Descriptive Analyses
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-descriptive Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis Analyses
Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-updated Utilization of Beta Blockers in the Pediatric Population: An Updated Descriptive Analysis Analyses
Utilization of Beta Blockers in the Pediatric Population: An Updated Descriptive Analysis
Analyses
https://sentinelinitiative.org/methods-data-tools/methods/utilization-single-and-multiple-inhaler-triple-therapy-among-patients Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database Methods, Data, & Tools
Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database
Methods, Data, & Tools
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-medication-use-patterns-among-pregnant-and Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System Publications and Presentations
Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/utilization-beta-blockers-among-pediatric-population-united Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022 Publications and Presentations
Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/variation-mother-infant-linkage-rates-jurisdiction-us Variation in Mother-Infant Linkage Rates by Jurisdiction in U.S. Medicaid Data Publications and Presentations
Variation in Mother-Infant Linkage Rates by Jurisdiction in U.S. Medicaid Data
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/principled-approaches-handle-partially-observed-confounder Principled Approaches to Handle Partially Observed Confounder Data from Electronic Health Records: A Plasmode Simulation Study Publications and Presentations
Principled Approaches to Handle Partially Observed Confounder Data from Electronic Health Records: A Plasmode Simulation Study
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/expanding-capabilities-unapproved-cannabis-derived-product Expanding Capabilities for Unapproved Cannabis-Derived Product Surveillance in the United States, TriNetX, July 1, 2018 – June 30, 2022 Publications and Presentations
Expanding Capabilities for Unapproved Cannabis-Derived Product Surveillance in the United States, TriNetX, July 1, 2018 – June 30, 2022
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/exploring-use-electronic-health-records-ehr-data-active Exploring the Use of Electronic Health Records (EHR) Data for Active Safety Surveillance of Epidiolex in PCORnet, July 1, 2018 - July 1, 2022 Publications and Presentations
Exploring the Use of Electronic Health Records (EHR) Data for Active Safety Surveillance of Epidiolex in PCORnet, July 1, 2018 - July 1, 2022
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-development-pregnancy-safety-study Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis Analyses
Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-development-pregnancy-safety-study-0 Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers Linked to Live-Birth Deliveries in the Mother-Infant Linkage Table: A Descriptive Analysis Analyses
Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers Linked to Live-Birth Deliveries in the Mother-Infant Linkage Table: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-public-workshop-optimizing-use-postapproval-pregnancy 2023 Public Workshop: Optimizing the Use of Postapproval Pregnancy Safety Studies Sentinel Initiative Events
2023 Public Workshop: Optimizing the Use of Postapproval Pregnancy Safety Studies
Sentinel Initiative Events
https://sentinelinitiative.org/methods-data-tools/methods/characterization-covid-19-vaccination-data-sdd-0 Characterization of COVID-19 Vaccination Data in the SDD Methods, Data, & Tools
Characterization of COVID-19 Vaccination Data in the SDD
Methods, Data, & Tools
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-15th-annual-sentinel-initiative-public-workshop 2023 15th Annual Sentinel Initiative Public Workshop Sentinel Initiative Events
2023 15th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
https://sentinelinitiative.org/methods-data-tools/methods/empirical-application-sentinel-electronic-health-record-ehr-and-claims Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests Methods, Data, & Tools
Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-cannabis-derived-product-users-national Characterization of Cannabis-Derived Product Users in the National Patient-Centered Clinical Research Network (PCORnet): A Descriptive Analysis Analyses
Characterization of Cannabis-Derived Product Users in the National Patient-Centered Clinical Research Network (PCORnet): A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/bimzelx-bimekizumab-bkzx Assessment of ARIA Sufficiency: Bimzelx (bimekizumab-bkzx) Sufficiency Assessments
Assessment of ARIA Sufficiency: Bimzelx (bimekizumab-bkzx)
Sufficiency Assessments
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-sentinel-innovation-and-methods-seminar-series 2024 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events
2024 Sentinel Innovation and Methods Seminar Series
Sentinel Initiative Events
https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pandemic-related-changes-healthcare-utilization-among-insured COVID-19 Pandemic Related Changes in Healthcare Utilization Among Insured Persons in the US and its Impact on Pharmacoepidemiologic Research Methods, Data, & Tools
COVID-19 Pandemic Related Changes in Healthcare Utilization Among Insured Persons in the US and its Impact on Pharmacoepidemiologic Research
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-baloxavir-use-signal Outcome Monitoring Following Baloxavir Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Baloxavir Use: A Signal Identification Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/smdi-r-package-perform-structural-missing-data smdi: An R Package to Perform Structural Missing Data Investigations on Partially Observed Confounders in Real-world Evidence Studies Publications and Presentations
smdi: An R Package to Perform Structural Missing Data Investigations on Partially Observed Confounders in Real-world Evidence Studies
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-biopsy Coding Trend Analyses: Biopsy Methods, Data, & Tools
Coding Trend Analyses: Biopsy
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-crohns-disease Coding Trend Analyses: Crohn's Disease Methods, Data, & Tools
Coding Trend Analyses: Crohn's Disease
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-colectomy-colostomy-and-ileostomy Coding Trend Analyses: Colectomy, Colostomy, and Ileostomy Methods, Data, & Tools
Coding Trend Analyses: Colectomy, Colostomy, and Ileostomy
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-diverticulitis-and-colitis Coding Trend Analyses: Diverticulitis and Colitis Methods, Data, & Tools
Coding Trend Analyses: Diverticulitis and Colitis
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-endoscopy Coding Trend Analyses: Endoscopy Methods, Data, & Tools
Coding Trend Analyses: Endoscopy
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-ulcerative-colitis Coding Trend Analyses: Ulcerative Colitis Methods, Data, & Tools
Coding Trend Analyses: Ulcerative Colitis
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/methods/maintaining-and-expanding-reach-sentinel-ehr-and-claims-network-di8 Maintaining and Expanding the Reach of the Sentinel EHR and Claims Network (DI8) Methods, Data, & Tools
Maintaining and Expanding the Reach of the Sentinel EHR and Claims Network (DI8)
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/singulair-montelukast-0 Singulair (Montelukast) & Intentional Self-Harm Studies
Singulair (Montelukast) & Intentional Self-Harm
Studies
https://sentinelinitiative.org/news-events/publications-presentations/targeted-learning-undersmoothed-lasso-propensity-score-model Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies Publications and Presentations
Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/litfulo-ritlecitinib Litfulo (Ritlecitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism & Stroke Studies
Litfulo (Ritlecitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism & Stroke
Studies
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/jesduvroq-daprodustat Assessment of ARIA Sufficiency: Jesduvroq (daprodustat) Sufficiency Assessments
Assessment of ARIA Sufficiency: Jesduvroq (daprodustat)
Sufficiency Assessments
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-over-time-development-pregnancy-safety Utilization of Products Over Time for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis Analyses
Utilization of Products Over Time for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/opportunities-and-challenges-use-large-language-models Opportunities and Challenges in the use of Large Language Models for Post-Marketing Surveillance of Medical Products Sentinel Initiative Events
Opportunities and Challenges in the use of Large Language Models for Post-Marketing Surveillance of Medical Products
Sentinel Initiative Events
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/validation-hospitalized-covid-19-diagnosis-detected-claims Validation of Hospitalized COVID-19 Diagnosis Detected from Claims-Based Algorithms: A Descriptive Analysis Analyses
Validation of Hospitalized COVID-19 Diagnosis Detected from Claims-Based Algorithms: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/hydrochlorothiazide-1 Hydrochlorothiazide & Utilization Studies
Hydrochlorothiazide & Utilization
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/hydrochlorothiazide-use-following-labeling-update-include-0 Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis Analyses
Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/cannabinoid-products Cannabinoid Products & Cohort Characterization Studies
Cannabinoid Products & Cohort Characterization
Studies
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/rezdiffra-resmetirom Assessment of ARIA Sufficiency: Rezdiffra (resmetirom) Sufficiency Assessments
Assessment of ARIA Sufficiency: Rezdiffra (resmetirom)
Sufficiency Assessments
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/vafseo-vadadustat Assessment of ARIA Sufficiency: Vafseo (vadadustat) Sufficiency Assessments
Assessment of ARIA Sufficiency: Vafseo (vadadustat)
Sufficiency Assessments
https://sentinelinitiative.org/studies/drugs/entyvio-vedolizumab-and-tysabri-natalizumab Entyvio (Vedolizumab) and Tysabri (Natalizumab) & Interstitial Lung Disease Studies
Entyvio (Vedolizumab) and Tysabri (Natalizumab) & Interstitial Lung Disease
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/interstitial-lung-disease-ild-patients-inflammatory-bowel Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis Analyses
Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/interstitial-lung-disease-ild-rates-patients-inflammatory Interstitial Lung Disease (ILD) Rates in Patients with Inflammatory Bowel Disease (IBD) and Following IBD Advanced Therapy: A Descriptive Analysis Analyses
Interstitial Lung Disease (ILD) Rates in Patients with Inflammatory Bowel Disease (IBD) and Following IBD Advanced Therapy: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/interstitial-lung-disease-algorithm-defined Interstitial Lung Disease Algorithm Defined in "Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis" Methods, Data, & Tools
Interstitial Lung Disease Algorithm Defined in "Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/interstitial-lung-disease-algorithm-defined-0 Interstitial Lung Disease Algorithm Defined in "Interstitial Lung Disease (ILD) Rates in Patients with Inflammatory Bowel Disease (IBD) and Following IBD Advanced Therapy: A Descriptive Analysis" Methods, Data, & Tools
Interstitial Lung Disease Algorithm Defined in "Interstitial Lung Disease (ILD) Rates in Patients with Inflammatory Bowel Disease (IBD) and Following IBD Advanced Therapy: A Descriptive Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/tryvio-aprocitentan Assessment of ARIA Sufficiency: Tryvio (aprocitentan) Sufficiency Assessments
Assessment of ARIA Sufficiency: Tryvio (aprocitentan)
Sufficiency Assessments
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2007 Duration of Follow Up for New Molecular Entities Approved in 2007: A Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2007: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/voydeya-danicopan Assessment of ARIA Sufficiency: Voydeya (danicopan) Sufficiency Assessments
Assessment of ARIA Sufficiency: Voydeya (danicopan)
Sufficiency Assessments
https://sentinelinitiative.org/studies/drugs/new-molecular-entities-nmes New Molecular Entities (NMEs) & Utilization Characterization Studies
New Molecular Entities (NMEs) & Utilization Characterization
Studies
https://sentinelinitiative.org/news-events/publications-presentations/general-framework-developing-computable-clinical-phenotype A General Framework for Developing Computable Clinical Phenotype Algorithms Publications and Presentations
A General Framework for Developing Computable Clinical Phenotype Algorithms
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/finding-uncoded-anaphylaxis-electronic-health-records Finding Uncoded Anaphylaxis in Electronic Health Records to Estimate the Sensitivity of ICD10 Codes Publications and Presentations
Finding Uncoded Anaphylaxis in Electronic Health Records to Estimate the Sensitivity of ICD10 Codes
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/duvyzat-givinostat Assessment of ARIA Sufficiency: Duvyzat (givinostat) Sufficiency Assessments
Assessment of ARIA Sufficiency: Duvyzat (givinostat)
Sufficiency Assessments
https://sentinelinitiative.org/studies/drugs/brexafemme-ibrexafungerp Brexafemme (Ibrexafungerp) & Use in Pregnancy Studies
Brexafemme (Ibrexafungerp) & Use in Pregnancy
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-patients-updated Utilization of Ibrexafungerp in Pregnant Patients: An Updated Descriptive Analysis in TriNetX Analyses
Utilization of Ibrexafungerp in Pregnant Patients: An Updated Descriptive Analysis in TriNetX
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/concomitant-use-medications-drug-drug-interactions Concomitant Use of Medications with Drug-Drug Interactions with Nirmatrelvir and Ritonavir Among Patients Treated with Nirmatrelvir and Ritonavir or Patients with COVID-19: A Descriptive Analysis Analyses
Concomitant Use of Medications with Drug-Drug Interactions with Nirmatrelvir and Ritonavir Among Patients Treated with Nirmatrelvir and Ritonavir or Patients with COVID-19: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-follow Utilization of Beta Blockers in the Pediatric Population: A Follow Up Updated Descriptive Analysis Analyses
Utilization of Beta Blockers in the Pediatric Population: A Follow Up Updated Descriptive Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/principled-approach-characterize-and-analyze-partially A Principled Approach to Characterize and Analyze Partially Observed Confounder Data from Electronic Health Records Publications and Presentations
A Principled Approach to Characterize and Analyze Partially Observed Confounder Data from Electronic Health Records
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/transparency-reproducibility-and-replicability Transparency, Reproducibility, and Replicability of Pharmacoepidemiology Studies in a Distributed Network Environment Publications and Presentations
Transparency, Reproducibility, and Replicability of Pharmacoepidemiology Studies in a Distributed Network Environment
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-users-new-molecular-entities-approved-0 Characterization of Users of New Molecular Entities Approved in 2021 in TriNetX: An Updated Descriptive Analysis Analyses
Characterization of Users of New Molecular Entities Approved in 2021 in TriNetX: An Updated Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/enterovirus Enterovirus & Neonatal Enteroviral Sepsis Studies
Enterovirus & Neonatal Enteroviral Sepsis
Studies
https://sentinelinitiative.org/studies/drugs/hydroxyurea Hydroxyurea & Use by Indication Studies
Hydroxyurea & Use by Indication
Studies
https://sentinelinitiative.org/studies/characterization-influenza-complications-among-individuals-diagnosed-influenza-illness Characterization of Influenza Complications Among Individuals Diagnosed with Influenza‐Like Illness, Pneumonia and Influenza, and Medically Attended Acute Respiratory Illness: A Descriptive Analysis Analyses
Characterization of Influenza Complications Among Individuals Diagnosed with Influenza‐Like Illness, Pneumonia and Influenza, and Medically Attended Acute Respiratory Illness: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/data-quality-review-and-characterization-programs Data Quality Review and Characterization Programs Methods, Data, & Tools
Data Quality Review and Characterization Programs
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/sentinel-common-components-sas-program-package Sentinel Common Components SAS® Program Package Common Data Model
Sentinel Common Components SAS® Program Package
Common Data Model
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-pediatric-demographics-and-enrollment-0 Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: An Updated Descriptive Analysis Analyses
Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: An Updated Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/angiotensin-converting-enzyme-ace-inhibitors-and-angiotensin-ii-receptor-blockers-0 Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Pediatric Drug Utilization Studies
Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Pediatric Drug Utilization
Studies
https://sentinelinitiative.org/news-events/publications-presentations/description-active-risk-identification-and-analysis-system A Description of the Active Risk Identification and Analysis System of the U.S. Food and Drug Administration Publications and Presentations
A Description of the Active Risk Identification and Analysis System of the U.S. Food and Drug Administration
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/us-food-and-drug-administration-s-sentinel-system-post The U.S. Food and Drug Administration’s Sentinel System: A Post-Market Active Drug Safety Surveillance System Publications and Presentations
The U.S. Food and Drug Administration’s Sentinel System: A Post-Market Active Drug Safety Surveillance System
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/innovative-methods-evaluating-medical-product-safety-and Innovative Methods for Evaluating Medical Product Safety and Effectiveness Using Real World Data: The U.S. Food and Drug Administration’s Sentinel Innovation Center Publications and Presentations
Innovative Methods for Evaluating Medical Product Safety and Effectiveness Using Real World Data: The U.S. Food and Drug Administration’s Sentinel Innovation Center
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/pharmacogenetic-testing Pharmacogenetic Testing & Characteristics and Metrics Studies
Pharmacogenetic Testing & Characteristics and Metrics
Studies
https://sentinelinitiative.org/studies/drugs/covid-19 COVID-19 & Venous Thromboembolism (VTE) and Arterial Thromboembolism (ATE) Studies
COVID-19 & Venous Thromboembolism (VTE) and Arterial Thromboembolism (ATE)
Studies
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/winrevair-sotatercept Assessment of ARIA Sufficiency: Winrevair (sotatercept) Sufficiency Assessments
Assessment of ARIA Sufficiency: Winrevair (sotatercept)
Sufficiency Assessments
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/voquezna-vonoprozan Assessment of ARIA Sufficiency: Voquezna (vonoprozan) Sufficiency Assessments
Assessment of ARIA Sufficiency: Voquezna (vonoprozan)
Sufficiency Assessments
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/zepbound-tirzepatide Assessment of ARIA Sufficiency: Zepbound (tirzepatide) Sufficiency Assessments
Assessment of ARIA Sufficiency: Zepbound (tirzepatide)
Sufficiency Assessments
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/leqembi-lecanemab-irmb Assessment of ARIA Sufficiency: Leqembi (lecanemab-irmb) Sufficiency Assessments
Assessment of ARIA Sufficiency: Leqembi (lecanemab-irmb)
Sufficiency Assessments
https://sentinelinitiative.org/news-events/publications-presentations/triple-challenges-small-sample-size-both-exposure-and Triple challenges – Small Sample Size in Both Exposure and Control Groups to Scan Rare Maternal Outcomes in a Signal Identification Approach: A Simulation Study Publications and Presentations
Triple challenges – Small Sample Size in Both Exposure and Control Groups to Scan Rare Maternal Outcomes in a Signal Identification Approach: A Simulation Study
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/serious-infection-algorithm-defined-serious-infection Serious Infection Algorithm Defined in "Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools
Serious Infection Algorithm Defined in "Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/serious-infection-following-ustekinumab-use-patients-crohn-0 Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis Analyses
Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/xofluza-baloxavir Xofluza (Baloxavir) & Signal Identification Studies
Xofluza (Baloxavir) & Signal Identification
Studies
https://sentinelinitiative.org/news-events/publications-presentations/use-sentinel-system-examine-medical-product-use-and-outcomes Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy Publications and Presentations
Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/software-packages-toolkits/centers-medicare-and-medicaid-services-cms-medicaid The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format Methods, Data, & Tools
The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-dipeptidyl-peptidase-4-dpp-4 Counts and Characteristics of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor or Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor Users with Type 2 Diabetes: A Descriptive Analysis Analyses
Counts and Characteristics of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor or Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor Users with Type 2 Diabetes: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/dupixent-dupilumab Dupixent (Dupilumab) & Signal Identification Studies
Dupixent (Dupilumab) & Signal Identification
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-dupilumab-use-signal-0 Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis
Analyses
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/overview-cder-s-real-world-evidence-demonstration-projects Overview of CDER’s Real-World Evidence Demonstration Projects Sentinel Initiative Events 08/05/2024
Overview of CDER’s Real-World Evidence Demonstration Projects
Sentinel Initiative Events
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-ispe-annual-meeting 2024 ISPE Annual Meeting Sentinel Initiative Events 08/24/2024
2024 ISPE Annual Meeting
Sentinel Initiative Events